Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romane Joudinaud

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|September 7, 2021
Stem Cells in Myelodysplastic Syndromes and Acute Myeloid Leukemia: First Cousins or Unrelated Entities?Romane Joudinaud, Thomas Boyer
Haematologica|March 20, 2025
NPM1 mutation subtype switch in acute myeloid leukemiaBenjamin Podvin, Romane Joudinaud, Christophe Roumier, et al.
Biochemia Medica|October 19, 2019
Classical pathway activity C3c, C4 and C1-inhibitor protein reference intervals determination in EDTA plasmaBenjamin Lopez, Nicolas Bertier, Emmanuel Ledoult, et al.
BMC Bioinformatics|October 28, 2022
Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3rAugustin Boudry, Sasha Darmon, Nicolas Duployez, et al.
British Journal of Haematology|September 3, 2025
Monitoring of measurable residual disease by next-generation sequencing in patients with acute myeloid leukaemiaAugustin Boudry, Laure Goursaud, Delphine Lebon, et al.
Blood Advances|October 17, 2024
Midostaurin shapes macroclonal and microclonal evolution of FLT3-mutated acute myeloid leukemiaRomane Joudinaud, Augustin Boudry, Laurène Fenwarth, et al.
Blood Cancer Journal|June 24, 2022
A multiparametric niche-like drug screening platform in acute myeloid leukemiaReinaldo Dal Bello, Justine Pasanisi, Romane Joudinaud, et al.
Leukemia|April 27, 2022
Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemiaBryann Pardieu, Justine Pasanisi, Frank Ling, et al.
Blood|May 21, 2026
Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapyNicolas Duployez, Romane Joudinaud, Augustin Boudry, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|September 7, 2021
Stem Cells in Myelodysplastic Syndromes and Acute Myeloid Leukemia: First Cousins or Unrelated Entities?Romane Joudinaud, Thomas Boyer
Haematologica|March 20, 2025
NPM1 mutation subtype switch in acute myeloid leukemiaBenjamin Podvin, Romane Joudinaud, Christophe Roumier, et al.
Biochemia Medica|October 19, 2019
Classical pathway activity C3c, C4 and C1-inhibitor protein reference intervals determination in EDTA plasmaBenjamin Lopez, Nicolas Bertier, Emmanuel Ledoult, et al.
BMC Bioinformatics|October 28, 2022
Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3rAugustin Boudry, Sasha Darmon, Nicolas Duployez, et al.
British Journal of Haematology|September 3, 2025
Monitoring of measurable residual disease by next-generation sequencing in patients with acute myeloid leukaemiaAugustin Boudry, Laure Goursaud, Delphine Lebon, et al.
Blood Advances|October 17, 2024
Midostaurin shapes macroclonal and microclonal evolution of FLT3-mutated acute myeloid leukemiaRomane Joudinaud, Augustin Boudry, Laurène Fenwarth, et al.
Blood Cancer Journal|June 24, 2022
A multiparametric niche-like drug screening platform in acute myeloid leukemiaReinaldo Dal Bello, Justine Pasanisi, Romane Joudinaud, et al.
Leukemia|April 27, 2022
Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemiaBryann Pardieu, Justine Pasanisi, Frank Ling, et al.
Blood|May 21, 2026
Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapyNicolas Duployez, Romane Joudinaud, Augustin Boudry, et al.
Pageof 1